NEXTECH VI ONCOLOGY SCSP 13D and 13G filings for Tyra Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:47 pm Purchase | 2024-09-30 | 13G | Tyra Biosciences, Inc. TYRA | NEXTECH VI ONCOLOGY SCSP | 4,055,861 7.700% | 1,537,279 (+61.04%) | Filing |
| 2021-09-27 4:36 pm Purchase | 2021-09-17 | 13G | Tyra Biosciences, Inc. TYRA | NEXTECH VI ONCOLOGY SCSP | 2,518,582 5.900% | 2,518,582 (New Position) | Filing |